A61K 49/0058
Antibodies
Official title: {Antibodies}
A61K49/0058 (Antibodies) appears on 438 US grants and 744 published applications in this corpus.
Search patents in A61K- Granted patents
- 438
- Published applications
- 744
- Assignees
- 362
- Inventors
- 1,564
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 4 |
| 2002 | 4 | 10 |
| 2003 | 5 | 8 |
| 2004 | 2 | 13 |
| 2005 | 2 | 7 |
| 2006 | 1 | 14 |
| 2007 | 3 | 15 |
| 2008 | 7 | 17 |
| 2009 | 6 | 16 |
| 2010 | 7 | 16 |
| 2011 | 8 | 30 |
| 2012 | 13 | 33 |
| 2013 | 24 | 45 |
| 2014 | 26 | 32 |
| 2015 | 21 | 36 |
| 2016 | 23 | 58 |
| 2017 | 34 | 31 |
| 2018 | 20 | 47 |
| 2019 | 31 | 52 |
| 2020 | 29 | 51 |
| 2021 | 32 | 34 |
| 2022 | 15 | 36 |
| 2023 | 29 | 36 |
| 2024 | 20 | 55 |
| 2025 | 24 | 22 |
| 2026 | 12 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibody conjugates and uses thereof6 Oct 2026US 12,753,242 B2GlycoNex Inc.
- Antibodies targeting glioblastoma stem-like cells and methods of use thereof22 Sep 2026US 12,742,019 B2Wisconsin Alumni Research Foundation
- Anti-PD-1 antibodies1 Sep 2026US 12,723,079 B2PD-I Acquisition Group, LLC
- Antibody-based method to identify, purify, and manipulate cell types and processes30 Jun 2026US 12,668,644 B2Albert Einstein College of Medicine
- Compounds for fast and efficient click release16 Jun 2026US 12,653,914 B2Tagworks Pharmaceuticals B.V.
- Method for detecting a gd2 positive cancer8 Oct 2026US 2026/0306677 A1Prinses Maxima Centrum Voor Kinderoncologie B.V.
- Antibodies targeting s100 proteins and uses thereof1 Oct 2026US 2026/0297172 A1Albert Einstein College of Medicine
- Anti-pd-l1 nanobody, preparation method therefor and use thereof1 Oct 2026US 2026/0297195 A1Kanglitai Biomedical (Qingdao) Co., Ltd.
- Novel anti-gprc5d antibody24 Sep 2026US 2026/0285972 A1Chimagen Biosciences, Ltd.
- Mutant fab fragment for obtaining site-specific mono-or bifunctionalised conjugates10 Sep 2026US 2026/0265367 A1
Most cited
By later US patents
- Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors228US 6,261,537 B1Nycomed Imaging AS · 2001
- Antibody conjugates reactive with human carcinomas196US 5,869,045 ABristol-Myers Squibb Company · 1999
- Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments180US 5,716,595 AImmunomedics, Inc. · 1998
- Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy173US 6,096,289 AImmunomedics, Inc. · 2000
- Intramolecularly-quenched near infrared fluorescent probes148US 6,083,486 AThe General Hospital Corporation · 2000